Facts on Drugs Used in Chemotherapy
Active substance: Vinblastine sulfate
Manufacturer: Bedford Laboratories
Extract from the prescribing information:
"Aspermia has been reported in man. Animal studies suggest that teratogenic effects may occur."
"Patients treated for Hodgkin’s disease have developed leukemia following radiation therapy and administration of vinblastine sulfate in combination with other chemotherapy including agents known to intercalate with DNA."
The above has been extracted from the Vinblastine prescribing information on the Bedford Laboratories webpages.